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We investigated the effects of taurine supplementation on cycling time to exhaustion 
in cold conditions. Eleven males cycled to exhaustion at a power output equivalent to 
the mid-point between ventilatory threshold and maximum aerobic power following 15-
min rest in the cold (apparent temperature of ~ 4 C; air flow of 4.17 m∙s-1). Two-hours 
before, participants ingested taurine (50 mg∙kg-1) or placebo beverage. Pulmonary 
gases, carbohydrate (CHO) and fat oxidation, body temperatures, mean local sweat 
rate, heart rate, rate of perceived exertion (RPE) and thermal comfort were recorded. 
Time to exhaustion was not different between trials (taurine = 14.6 ± 4.7 min; placebo 
= 13.4 ± 5.6 min, P = 0.061, d = 0.27). There were no effects (P > 0.05) of taurine on 
core temperature, mean skin temperature or local sweat rates. However, the placebo 
condition showed greater (P < 0.05) reductions in arm-to-finger temperature gradient 
(i.e. vasodilation) across pre-exercise passive cold exposure and increased CHO 
oxidation (P < 0.05). Participants also reached a thermally ‘comfortable’ level quicker 
in the taurine condition (P < 0.05). A 50 mg∙kg-1 dose of taurine did not statistically 
benefit endurance exercise after moderate cold exposure but conferred some potential 
vascular and metabolic effects. 
 


















The sulphur-based amino acid, taurine, is found in abundance in human tissue, with 
comparatively high concentrations found in excitable cells of skeletal muscles and 
neurons (Huxtable, 1992). Taurine has been shown to facilitate skeletal muscle 
contractility and fatigue resistance by increasing Ca2+ uptake from the sarcoplasmic 
reticulum, as well as improving the sensitivity of contractile filaments to the presence 
of Ca2+ (Bakker & Berg, 2002; Hamilton et al., 2006). Taurine is also found in higher 
concentrations in type I compared to type II muscle fibres (Harris et al., 1998). Here, 
it acts as a buffer to maintain the mitochondrial pH across the inner membrane, thus 
enhancing efficiency of oxidative metabolism (Hansen et al, 2010). Others have 
reported an anti-oxidative effect of taurine supplementation and corresponding 
increases in aerobic capacity (Zhang et al., 2004). These potential effects on muscle 
contractility and oxidative efficiency or capacity might explain the ergogenic effects 
elicited by oral taurine supplementation in humans, leading to improvements in 
maximal muscle force production (Lim et al., 2018), endurance (Balshaw et al., 2013; 
Waldron et al. 2018a; 2018c), or intermittent performance (Warnock et al., 2017), as 
well as improved exercise efficiency (Paulucio et al., 2017). Indeed, despite some 
studies demonstrating no overall performance effects of taurine supplementation, the 
reported increases in fat oxidation rates have indicated enhanced metabolic efficiency 
and potential for glycogen sparing (Rutherford et al., 2010; De Carvalho et al., 2018). 
These effects could be more noticeable in environments where metabolic demand and 
glycogen utilisation are increased, such as during cold exposure (Jacobs et al., 1985; 
Martineau & Jacobs, 1988).    
 
Exercise in cold environments presents a significant challenge to thermoregulation, 
with exaggeration of the thermal gradient from core-to-environment facilitating heat 
loss, primarily via convective and conductive pathways (Young & Castellani, 2001). 
Cold exposure elicits reflex increases in efferent skin sympathetic activity, leading to 
peripheral vasoconstriction and reductions in skin blood flow to delay heat losses 
(Castellani & Young, 2016). These thermoregulatory reflexes occur when skin surface 
temperature decreases ∼3-4 °C below a thermoneutral threshold of ~34 °C (Greaney 
et al., 2015). During prolonged cold exposure, shivering becomes important for 
thermoregulation to generate metabolic body heat (Castellani & Young, 2016). Initial 
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vasoconstriction leads to increased intra-thoracic pressure, central blood pressure, 
cardiac output and myocardial oxygen demand (Doubt, 1991). Thus, coupled with the 
thermogenic (shivering) responses, the primary effects of cold exposure increase the 
net O2 cost at rest and exercise (Cheuvront et al. 2001). Higher rates of glycogenolysis 
are also observed in cold, driven by increased activation of the sympathetic nervous 
system due to cold exposure (Jacobs et al., 1985; Martineau & Jacobs, 1988). 
Collectively, these acute physiological responses to moderately cold exposure could 
have negative effects on exercise efficiency, potentially leading to an earlier onset of 
fatigue and impaired endurance performance (Galloway & Maughan, 1997).  
 
It is feasible that the suggested enhancement of exercise efficiency and relative 
preference for fat oxidation induced by taurine ingestion might offset the deleterious 
effects of cold exposure on endurance exercise. However, the vaso-active properties 
of taurine complicate this reasoning. For example, oral administration of taurine can 
elicit vasodilatory effects on the peripheral vasculature (Sun et al., 2016; Ulusoy et al., 
2017), which have been suggested to contribute to the control of central blood 
pressure in thermally neutral environments (Waldron et al., 2018b). Indeed, there is 
some evidence to support taurine’s role in suppression of sympathetic nervous system 
activity (Mizushima, 1996; Hano, 2009). Thus, taurine-induced peripheral vasodilation 
could potentially work in opposition to the acute vasoconstriction typically observed 
during cold exposure. Whilst this might assist in offsetting cold-induced blood pressure 
increases, it is also likely to enhance heat dissipation via convective pathways, 
particularly when skin-surface convective air flow is high (Ishigaki et al., 1993). 
However, taurine’s roles in rodent vasculature are known to differentially modulate 
vascular wall function to maintain haemodynamic homeostasis, which is dependent 
on the background muscle tone (Nishida & Satoh, 2009). In this instance, it is possible 
that increasing the presence of plasma taurine could counteract the cold-induced 
hyper-excitable vasculature tone, acting to maintain homeostasis of blood flow. 
Therefore, it is unclear whether taurine administration will facilitate or impair peripheral 
temperature and blood flow during exercise and whether this will affect tolerance to 
the cold.   
 
The purpose of this study was to examine the effects of acute taurine (50 mg∙kg-1) 
ingestion on thermoregulation and cycling time to exhaustion (TTE) in cold conditions 
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7 C dry bulb temperature, with high air flow (4.17 m∙s-1; apparent temperature ~ 4 C) 
at a sub-maximal intensity, corresponding to the mid-point between the ventilatory 
threshold and maximal aerobic power (VT∆50). It was hypothesised that taurine would 
improve TTE in the cold and that whole-body metabolic substrate utilisation would be 






Eleven healthy males provided written informed consent to take part in this study (age 
23 ± 5 years, stature 181.2 ± 5.1 cm, body mass 79.4 ± 8.3 kg, maximal oxygen uptake 
(?̇?O2max) 40.1 ± 4.3 ml∙ kg-1∙min-1, maximum aerobic power 267 ± 25 W). Participants 
were recruited from university and local sports clubs, and had various endurance 
backgrounds such as cycling, rowing and football. G* Power (Version 3.0.10; 
Universität Düsseldorf, Germany) was used to determine an a priori sample size of 10, 
using the t-test matched pairs function, with an alpha level of 0.95 and a 1-𝛽 of 0.80, 
and an Cohen’s d effect size of 1.14 (Waldron et al. 2018a). Participants were 
requested to refrain from any nutritional supplementation or alcohol consumption, as 
well as avoiding strenuous exercise in the 48-h prior to testing. In addition, participants 
were instructed to eat the same pre-trial breakfast each time. Trials were all performed 
between the hours of 10:00 and 14:00. Ethical approval was granted by the ethics 
committee at St Mary’s University (SMEC_2017-18_053). 
 
Design 
This study was conducted using a double-blind, crossover design, with a randomly 
chosen treatment order following ?̇?O2max testing. Participants were required to visit the 
laboratory on three separate occasions, each at least 48-h apart. The initial visit for all 
participants involved a ?̇?O2max test to establish the subsequent TTE intensity. During 
the subsequent two visits, the participants ingested either taurine (50 mg∙kg-1 body 









During the first laboratory visit, participants performed an incremental test to volitional 
exhaustion to establish V̇O2max. The power output started at 112 W, with a ramp rate 
of 16 Wmin-1. All trials were conducted using a cadence of 80 revmin-1 using a 
mechanically-braked cycle ergometer (Monark Exercise AB, Ergomedic 874E, 
Varberg, Sweden). All subsequent trials were conducted using the same ergometer 
and seat height for each participant. Respiratory gases were collected and measured 
breath-by-breath (Jaeger Vyntus CPX, Hoechberg, Germany). Maximum aerobic 
power (MAP) was determined as the 30-s average power output that corresponded to 
V̇O2max. Breath-by-breath V̇O2 and V̇CO2 data from the incremental cycling test was 
used to plot ventilatory threshold (VT), using the simplified v-slope method (Scheider 
et al., 1993). The external power output corresponding to the mid-point between VT 





All experimental trials were conducted in an environmental chamber (Sporting Edge 
UK, Basingstoke, UK), in a controlled cold environment. Dry bulb temperature (Tdb) 
was set to 8 C, with a 24 inch fan (Sealey HVD24 Industrial High-Velocity Drum Fan, 
Jack Sealey Ltd., Suffolk, UK) set 1 m in front of the participant. Air flow from the fan 
generated a 4.17 m∙s-1 wind speed, creating an effective wind chill of 4.18 C, using 
the following equation (Quayle & Steadman, 1998): 
 
Wind chill = 1.41 – 1.162V + 0.980T + 0.0124V + 0.0185(VT)   [equation 1] 
where V = wind speed (m∙s-1), and T = air temperature (degrees Celsius). 
 
 Participants were exposed to these conditions from the moment they entered the 




Prior to entering the chamber, participants self-inserted a rectal thermistor (Edale 
instruments Ltd., Cambridge, UK) 10 cm beyond the anal sphincter to measure core 
temperature (Tcore). Skin thermistors (Grant Instruments Ltd., Cambridge, UK) were 
taped to the right quadriceps, right medial calf, right forearm and chest. Mean skin 
temperature (Tskin) was calculated as: Tskin = 0.3 x (Tchest + Tarm) + 0.2 x (Tthigh + Tcalf) 
(Ramanathan, 1964). An additional thermistor was fitted to the dorsal aspect of the 
right index finger in order to measure arm-to-finger temperature gradient (House & 
Tipton, 2002). Tcore and Tskin were continuously recorded from the point of entering the 
chamber until the end of the trial using a data logger (SQ2010, Grant Instruments Ltd., 
Cambridge, UK).  
 
On entering the chamber, the participants mounted the ergometer and sat passively 
resting for 15-min pre-exercise. This period was used to induce mild cold stress in the 
participants based on the early profiles demonstrated in response to these 
environmental conditions (Muza et al., 1988). In the final 2-min of the 15-min rest 
period, a face mask was fitted and breath-by-breath gases were recorded until the end 
of the trial (Jaeger Vyntus CPX, Hoechberg, Germany). V̇O2, V̇CO2, minute ventilation 
(V̇e) and respiratory exchange ratio (RER) were recorded. The TTE commenced at 
VT∆50 for 15-min at 80 revmin-1 and continued to volitional exhaustion. Strong verbal 
encouragement was given repeatedly at 1-minute intervals throughout the trial. 
Encouragement became constant if cadence dropped below 75 revmin-1, and trials 
were ended where cadence had dropped below 70 revmin-1 for longer than 5-s. Heart 
rate (HR) and thermal comfort (on an 8-point scale, where 0 = “unbearably cold”, 4 = 
“comfortable” and 8 = “unbearably hot” (Young et al., 1987) were recorded at 5-min 
intervals during the 15-min rest period and at 1-min intervals during the TTE. Ratings 
of perceived exertion (6-20; RPE) were recorded a 1-min intervals during the TTE. 
 
Whole-body rates of carbohydrate (CHO) and fat oxidation were calculated during the 
TTE, using V̇O2 and V̇CO2 collected from gas analysis. The non-protein RER was 
used, according to Peronnet and Massicotte (1991): 
 
 




Fat oxidation (g∙min-1) = [1.695 × V̇O2 (L∙min-1)]–[1.701 × V̇CO2 (L∙min-1)]            [equation 3] 
Local sweat rates  
 
Local sweat rate was measured using a Q-Sweat system (WRMedical ElectronicsCo., 
Stillwater, MN). Ventilated capsules were fixed proximal to the skin thermistors on the 
right side of the body. Dry air was continuously delivered through Teflon-lined tygon 
tubing at a fixed flow rate of 60 sccm∙min−1 between four separate sweat capsules 
(size = 0.781 cm2) mounted on the skin’s surface and the Q-sweat device. Fluid 
released from the sweat glands is transiently incorporated into the dry air, with the 
change in temperature and relative humidity monitored by the Q-Sweat device. Sweat 
rate was calculated using standard vapour pressure equations and expressed in 
nL∙min−1. Mean sweat rate was calculated by averaging the four sweat sites and 
reported every 1-min. Mean sweat rate data (nL∙min−1) as a mean of the four sites was 




All taurine supplements were prepared in powder form and weighed using an 
analytical balance (Precisa 125A; Precisa Gravimetrics AG, Zurich, Switzerland). Both 
taurine and placebo supplements were prepared and ingested in 250 ml water using 
a non-caloric sweetener (strawberry). Drinks were administered 2-h prior to 
commencement of the trials. The 2-h timeframe has previously been reported to allow 
plasma taurine levels to reach peak level (Ghandforoush-Sattari et al., 2010). Dosage 
of 50 mg∙kg-1 body mass was in agreement with previous studies (Waldron et al., 
2018a; Warnock, et al., 2017), and all supplements were sourced from the same 
company (My Protein, Manchester, UK). Participants were not asked if they could 
identify the substance being ingested in either trial. None voluntarily suggested they 









A two-way repeated measures analysis of variance (RM-ANOVA) was conducted 
using condition (taurine or placebo) and time (10% epochs during TTE) as the 
independent variables. During the 15-min pre-exercise period, time was separated into 
three levels (0-5-min, 5-10-min and 10-15-min). Where the assumption of sphericity 
was violated, a Greenhouse-Geisser correction was applied. Post-hoc Bonferroni tests 
were used to determine pairwise effects. A paired samples t-test was used to identify 
differences in TTE between conditions. Statistical significance was accepted at P < 
0.05. Analysis was carried out using IBM SPSS Statistics (Version 24; IBM Corp., 
Armonk, NY, USA). Cohen’s d effect sizes (ES ± 95% confidence intervals) were 
calculated, with thresholds set as: 0.2 small; 0.6 moderate; 1.2 large; 2.0 very large 





Pre-exercise passive rest 
Tcore, Tskin and arm-to-finger temperature gradients during the pre-exercise passive 
resting period are shown in Figure 1. There were no condition (F(1,10) = 0.583, P = 
0.463) or time effects on Tcore (F(2,20) = 0.489, P = 0.620) across the 15-min pre-
exercise period. Similarly, there were no condition effects on Tskin (F(1,8) = 0.030, P = 
0.869), yet there was a decline across time (F(2,16) = 4.28, P = 0.019). The arm-to-
finger gradient was also not affected by condition (F(1,8) = 0.02, P = 0.886), but did 
decrease across time (F(2,16) = 5.05, P = 0.026) and an interaction with condition (P = 
0.047), with post-hoc tests revealing differences between 0-5 min and 10-15 min in 





Figure 1. Mean ± SD for arm-to-skin temperature gradient (A), mean skin 
temperature (B) and core temperature (C) during 0-5 min, 5-10 min and 10-15 
min of pre-exercise seated rest in simulated cold (7 °C) and windy (4.17 m∙s-1) 




During the pre-exercise period, there were no condition (F(1,10) = 0.132, P = 0.724) or 
time (F(2,20) = 0.449, P = 0.645) effects for heart rate (Taurine = 77 ± 11 vs. placebo = 
77 ± 12 beats∙min-1). There were also no effects of condition on thermal comfort (F(1,10) 
= 1.070, P = 0.325; Taurine = 1.7 ± 0.7 vs. Placebo = 1.8 ± 0.8) but there were effects 
for time, showing a decrease in thermal comfort across the three pre-exercise stages 









There was no difference in TTE between taurine and placebo conditions (t(10) = 2.112 
P = 0.061, d = 0.27; Taurine = 14.2 ± 5.2-min vs. Placebo = 13.7 ± 5.2-min).  
 
Thermal responses to TTE trials  
 
Tcore increased across time (F(9,81) = 11.734, P < 0.001) but there was no effect of 
condition (F(1,9) = 1.051, P = 0.332) (Figure 2E). Tskin was not affected by condition 
(F(1,8) = 3.262, P = 0.114) but it did increase across time (F(9,73) = 9.864, P < 0.001) 
(Figure 2C). There were no condition effects on arm-to-finger gradient (F(1,8) = 1.997, 
P = 0.207) but there was a decrease over time (F(9,73) = 7.309, P < 0.001) (Figure 2A).  
 
Sweat responses to TTE 
 
Mean local sweat rates were not different between conditions (F(1,10) = 0.231, P = 
0.641) but increased across time (F(9,90) = 7.585, P < 0.001), with no interactions (P = 
0.998) (Figure 2B). 
 
Perceptual responses to TTE trials  
 
There were condition (F(1,10) = 5.813, P = 0.037) and time effects (F(9,90) = 5.813, P = 
0.037), showing increased thermal comfort in the taurine condition (F(9,90) = 14.365, P 
< 0.001), but no interactions (P = 0.279) (Figure 2F). There were no condition effects 
for RPE (F(1,10) = 3.721, P = 0.083), but there was an increase across time (F(9,90) = 
172.385, P < 0.001) and interactions with condition, showing taurine increased RPE 
(F(9,90) = 4.785, P < 0.001) (Figure 2D). Post-hoc tests revealed differences between 
conditions at 10% (P = 0.001, d = 0.58), 20% (P = 0.031, d = 0.70), 40% (P = 0.01, d 








Figure 2. Mean ± SD for arm-to-finger temperature gradient (A), mean of local sweat 
rates (B), mean skin temperature (C), RPE (D), core temperature (E) and thermal 
comfort (F) during 10% epochs of time to exhaustion in cold (7 °C) and windy (4.17 
m∙s-1) conditions. ƚ = main effect of time.  ᵠ = interaction between condition and time. 




Cardiorespiratory responses to TTE 
 
Heart rate was not different between conditions (F(1,10) = 1.200, P = 0.302) but 
increased across the trial (F(9,90) = 122.702, P < 0.001), with no interaction effects (P 
= 0.439). V̇O2 (F(1,10) = 0.029, P = 0.868), V̇CO2 (F(1,10) = 0.521, P = 0.487), V̇e (F(1,10) 
= 0.354, P = 0.656) and RER (F(1,10) = 0.318, P = 0.105) were not different between 
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conditions but were each increased across time (P < 0.05) (Figure 3). There was an 
interaction between condition and time for V̇CO2 (F(9,90) = 2.909, P = 0.005), but no 




Figure 3. Mean ± SD of minute ventilation (V̇e) (A), carbon dioxide production (V̇CO2) 
(B), oxygen consumption (V̇O2) (C), during 10% epochs of time to exhaustion in cold 
(7 °C) and windy (4.17 m∙s-1) conditions. ƚ = main effect of time. φ  = interaction between 
condition and time.  
  
Fat and carbohydrate oxidation during TTE trials  
 
CHO oxidation rates were lower in the taurine condition (t(10) = 2.23, P = 0.049, d = 
0.91), but there were no differences between conditions in fat oxidation rates (t(10) = 





Figure 4. Mean ± SD of carbohydrate and fat oxidation rates during exercise in cold 
























This study investigated the effects of acute taurine supplementation on 
thermoregulation in cold conditions and its subsequent effect on exercise tolerance. 
Despite finding no statistically significant performance effects of taurine (d = 0.27, 
8.7%, P = 0.061), there were small increases in TTE. There were no effects of taurine 
supplementation among many of the measured variables, relating to thermal control 
and physiological responses to cold or exercise. However, the observed reduction in 
pre-exercise, cold-induced arm-to-finger gradients in the placebo condition across the 
three 5-min stages were not found in the taurine condition. We also report a decreased 
CHO oxidation rate during cold exercise in the taurine compared to the placebo 
condition, alongside periods of lower V̇CO2 in the taurine condition, thus indicating an 
effect of taurine on whole-body metabolism and substrate utilisation. There was an 
increase in perceived exertion and thermal comfort following taurine supplementation, 
despite no changes in body temperature or work rate. Based on the current findings, 
there appears to be negligible-to-small effects of taurine on thermoregulation and 
exercise in mild cold, yet possible alterations in metabolic and vascular processes 
provide preliminary evidence of taurine’s potential roles in thermoregulatory control.  
 
There is growing evidence to suggest that endurance exercise, performed in 
thermoneutral environments, can be improved by acute supplementation of taurine 
(Waldron et al., 2018c; Souza et al., 2016). These benefits have been attributed to 
increases in muscle function and mechanical efficiency (Balshaw et al., 2013; Paulucio 
et al., 2017), increased fat oxidation (de Carvalho et al., 2018), as well as enhanced 
endurance capacity (Waldron et al., 2018a). We reasoned that these changes should, 
theoretically, counteract many of the negative effects of cold exposure on exercise 
efficiency. In partial support of our hypotheses, there were changes in substrate 
utilisation between conditions, with taurine supplementation moderately reducing  
whole-body CHO oxidation rate, and taurine eliciting small (yet non-significant) effects 
on fat oxidation. Exposure to cold conditions has been found to increase CHO 
metabolism (Jacobs et al., 1985; Martineau & Jacobs, 1988), which would also be the 
predominant substrate utilised to support exercise at the designated intensity (VT∆50). 
Thus, the reduced reliance on CHO utilisation in preference of small increases in fat 
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oxidation in the taurine condition could be important for prolonging exercise in the cold. 
Furthermore, these changes occurred without significant alterations in exercise 
intensity, exercise tolerance or heart rate. Therefore, we provide the first evidence that 
taurine supplementation could assist with exercise efficiency in the cold, partly via 
metabolic substrate utilisation changes. However, the physiological challenge 
presented by the whole-body cold stimulus, as demonstrated by hypothermal mean 
Tskin and perceptual data, appear to have dampened the more commonly reported 
ergogenic effects elicited by taurine, with other energy-demanding metabolic or 
thermoregulatory processes taking preference. A more prolonged exercise period at 
lower intensity might have been necessary to realise the effect of these alterations. 
We do not have evidence to provide a mechanism responsible for these changes but 
those suggested by others, such as activation of intra-cellular second messengers 
involved in substrate metabolism (Rutherford et al., 2010; de Carvalho et al., 2020), 
could explain the alteration in substrates used to support exercise. 
 
The statistically insignificant effects of taurine on TTE reported here should be 
considered alongside the ~ 8.7% small increases, which are typical of reports in 
thermoneutral environments (Waldron et al. 2018c) and similar to the 10% increase in 
TTE of an equivalent intensity reported by Page et al. (2019) in hot (~ 35 °C) 
conditions. The extended exercise tolerance in the heat was partly attributed to 
increased sweat production during the early stages of exercise, leading to reductions 
in Tcore (Page et al., 2019). In the current study, we did not find any effects of taurine 
on sweating, despite increases across time. Thus, it would appear that the hotter 
environmental stimulus is necessary to recognise the effects of taurine on sudomotor 
function and evaporative cooling potential. However, during the pre-exercise passive 
cold exposure period (which induced shivering, low Tskin temperatures set a ‘cold’ 
thermal sensation), there were significant reductions in arm-to-finger temperature 
gradient in the placebo group but not in taurine, which is indicative of less vasodilation 
(or greater sustained vascular tone) in the taurine condition when presented with a 
cold environmental stimulus (House & Tipton, 2002). These findings are surprising, 
given that taurine is typically shown to promote vasodilation of macro-vasculature in 
normothermia (Ulusoy et al., 2017; Sun et al., 2016), but could highlight a more 
particular role of taurine in the peripheral sub-cutaneous micro-vasculature in 
response to cold environments. Our results infer that the taurine supplement permitted 
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less vasodilation, thus delaying convective heat losses at the periphery. This could be 
related to the bimodal vaso-active properties of taurine shown in animal models to 
defend acute blood pressure changes (Nishida & Satoh, 2009) but further direct 
assessments of blood flow are needed to understand this. While the arm-to-finger 
differences were also non-significant during the exercise bout, the pre-exercise 
differences meant that the TTE commenced under different levels of shell-
temperature. It was anticipated that this would lead to enhanced Tcore in the taurine 
condition, which did not occur, despite descriptively higher values (~ 0.2 °C) pre- and 
during exercise.  
 
Increased thermal comfort in the taurine condition indicated that the participants 
reached a ‘comfortable’ perception of the environment more rapidly than without 
taurine ingestion. We attribute these results to the descriptive increases in body 
temperature following taurine ingestion, which have a known influence on thermal 
perception and behaviour (Schlader et al., 2013). Similarly, the increased RPE in the 
early stages of exercise might have been based on feedback from thermal afferents 
emanating from the receptors at the skin surface or peripheral vessels (Crewe et al., 
2008). The combination of the two current findings indicate that ingesting taurine in 
tolerably cold weather could enhance feelings of comfort at the expense of increased 




This is the first study to examine the effects of acute taurine supplementation on 
exercise performance in cold conditions. Although there were no effects on exercise 
performance, we have found preliminary evidence of possible effects on metabolic 
and vascular control processes. Future research should extend these findings to 
prolonged exercise at colder body temperatures, where the small effects revealed here 
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